Header Logo

Connection

Tammy Meyers to Child

This is a "connection" page, showing publications Tammy Meyers has written about Child.
Connection Strength

1,280
  1. Dolutegravir for children with HIV-associated tuberculosis. Lancet HIV. 2022 09; 9(9):e599-e600.
    View in: PubMed
    Score: 0,132
  2. Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis. AIDS. 2019 11 15; 33(14):2197-2203.
    View in: PubMed
    Score: 0,110
  3. Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa. AIDS. 2013 Mar 13; 27(5):781-5.
    View in: PubMed
    Score: 0,069
  4. Positive association between dietary iron intake and iron status in HIV-infected children in Johannesburg, South Africa. Nutr Res. 2013 Jan; 33(1):50-8.
    View in: PubMed
    Score: 0,068
  5. Changes in pediatric HIV-related hospital admissions and mortality in Soweto, South Africa, 1996-2011: light at the end of the tunnel? J Acquir Immune Defic Syndr. 2012 Aug 15; 60(5):503-10.
    View in: PubMed
    Score: 0,066
  6. Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa. Psychol Health Med. 2012; 17(5):599-610.
    View in: PubMed
    Score: 0,064
  7. Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa. Pediatr Infect Dis J. 2011 Nov; 30(11):974-9.
    View in: PubMed
    Score: 0,063
  8. Antiretroviral therapy for children in resource-limited settings: current regimens and the role of newer agents. Paediatr Drugs. 2011 Oct 01; 13(5):303-16.
    View in: PubMed
    Score: 0,062
  9. Case records of the Massachusetts General Hospital. Case 18-2010. A 7-year-old boy with elevated HIV RNA levels despite antiretroviral medications. N Engl J Med. 2010 Jun 17; 362(24):2305-12.
    View in: PubMed
    Score: 0,057
  10. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS. 2010 Jun 01; 24(9):1341-9.
    View in: PubMed
    Score: 0,057
  11. Six-month gain in weight, height, and CD4 predict subsequent antiretroviral treatment responses in HIV-infected South African children. AIDS. 2010 Jan 02; 24(1):139-46.
    View in: PubMed
    Score: 0,055
  12. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort. Int J Tuberc Lung Dis. 2009 Jul; 13(7):862-7.
    View in: PubMed
    Score: 0,053
  13. Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis. 2007 Dec 01; 196 Suppl 3:S474-81.
    View in: PubMed
    Score: 0,048
  14. Socioemotional and behavioural difficulties in children with chronic physical conditions: analysis of the Longitudinal Study of Australian Children. Arch Dis Child. 2023 07; 108(7):569-575.
    View in: PubMed
    Score: 0,035
  15. Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):201-204.
    View in: PubMed
    Score: 0,030
  16. T-helper cell responses among HIV-infected children in Soweto, South Africa. Ann N Y Acad Sci. 2000 Nov; 918:373-6.
    View in: PubMed
    Score: 0,029
  17. HIV infection and in-hospital mortality at an academic hospital in South Africa. Arch Dis Child. 2000 Sep; 83(3):227-30.
    View in: PubMed
    Score: 0,029
  18. Age-specific and sex-specific weight gain norms to monitor antiretroviral therapy in children in low-income and middle-income countries. AIDS. 2015 Jan 02; 29(1):101-9.
    View in: PubMed
    Score: 0,020
  19. Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa. Int J Tuberc Lung Dis. 2014 Jun; 18(6):676-81.
    View in: PubMed
    Score: 0,019
  20. Effect of baseline immune suppression on growth recovery in HIV positive South African children receiving antiretroviral treatment. J Acquir Immune Defic Syndr. 2012 Oct 01; 61(2):235-42.
    View in: PubMed
    Score: 0,017
  21. Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children. Eur J Clin Pharmacol. 2012 Apr; 68(4):339-47.
    View in: PubMed
    Score: 0,016
  22. Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C. J Acquir Immune Defic Syndr. 2011 Jan 01; 56(1):9-15.
    View in: PubMed
    Score: 0,015
  23. Efavirenz plasma concentrations at 1, 3, and 6 months post-antiretroviral therapy initiation in HIV type 1-infected South African children. AIDS Res Hum Retroviruses. 2010 Jun; 26(6):613-9.
    View in: PubMed
    Score: 0,014
  24. Effect of rifampicin on efavirenz pharmacokinetics in HIV-infected children with tuberculosis. J Acquir Immune Defic Syndr. 2009 Apr 15; 50(5):439-43.
    View in: PubMed
    Score: 0,013
  25. The utility of fine needle aspiration in HIV positive children. Cytopathology. 2008 Apr; 19(2):86-93.
    View in: PubMed
    Score: 0,012
  26. High prevalence of subtherapeutic plasma concentrations of efavirenz in children. J Acquir Immune Defic Syndr. 2007 Jun 01; 45(2):133-6.
    View in: PubMed
    Score: 0,012
  27. Surgeons are failing to recognize children with HIV infection. J Pediatr Surg. 2007 Feb; 42(2):431-4.
    View in: PubMed
    Score: 0,011
  28. Polymorphisms in Nef associated with different clinical outcomes in HIV type 1 subtype C-infected children. AIDS Res Hum Retroviruses. 2007 Feb; 23(2):204-15.
    View in: PubMed
    Score: 0,011
  29. Evaluation of dried whole blood spots obtained by heel or finger stick as an alternative to venous blood for diagnosis of human immunodeficiency virus type 1 infection in vertically exposed infants in the routine diagnostic laboratory. Clin Vaccine Immunol. 2007 Feb; 14(2):201-3.
    View in: PubMed
    Score: 0,011
  30. Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B. PLoS Med. 2006 Jul; 3(7):e255.
    View in: PubMed
    Score: 0,011
  31. Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression. AIDS Res Hum Retroviruses. 2006 May; 22(5):458-65.
    View in: PubMed
    Score: 0,011
  32. Barriers to disclosure to children with HIV. J Trop Pediatr. 2005 Oct; 51(5):285-7.
    View in: PubMed
    Score: 0,010
  33. Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children. Virus Genes. 2004 Apr; 28(3):311-8.
    View in: PubMed
    Score: 0,009
  34. Full-length genome characterization of HIV type 1 subtype C isolates from two slow-progressing perinatally infected siblings in South Africa. AIDS Res Hum Retroviruses. 2003 Nov; 19(11):1033-7.
    View in: PubMed
    Score: 0,009
  35. Human immunodeficiency virus type 1 envelope-stimulated interleukin-2 production and survival of infected children with severe and mild clinical disease. J Infect Dis. 2001 Sep 15; 184(6):691-8.
    View in: PubMed
    Score: 0,008
  36. Interleukin-8 concentrations in the peripheral circulation of human immunodeficiency virus type 1-infected children suggest blunted chemokine responses. Pediatr Infect Dis J. 2001 Aug; 20(8):819-20.
    View in: PubMed
    Score: 0,008
  37. Altered expression of L-selectin (CD62L) on polymorphonuclear neutrophils of children vertically infected with human immunodeficiency virus type 1. J Clin Immunol. 2001 Jul; 21(4):286-92.
    View in: PubMed
    Score: 0,008
  38. Defective neutrophil degranulation induced by interleukin-8 and complement 5a and down-regulation of associated receptors in children vertically infected with human immunodeficiency virus type 1. Clin Diagn Lab Immunol. 2001 Jan; 8(1):21-30.
    View in: PubMed
    Score: 0,007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.